UBX1325 Phase 2B ASPIRE Study 24- and 36-Week Data in DME Robert Bhisitkul, M.D., Ph.D. Professor of Ophthalmology, UCSF Anirvan Ghosh, CEO Federico Grossi, CMO Lynne Sullivan, CFO Alicia Tozier, Chief Strategy Officer March 24, 2025 1 Special Note Regarding Forward-Looking Statements This presentation and the accompanying oral commentary contain forward-looking statements including statements related to Unity Biotechnology Inc.'s ("UNITY's") understanding of cellular senescence and the role it plays in ret ...

Unity Biotechnology (UBX) Update / Briefing March 24, 2025 08:00 AM ET Speaker0 Good morning, and welcome to the Unity Biotechnology Conference Call and Webcast. At this time, all attendees are in a listen only mode. A question and answer session will follow the formal presentations. As a reminder, this call is being recorded and a replay will be made available on the Unity website following the conclusion of the event. I'd now like to turn the call over to Lynn Sullivan, Chief Financial Officer of Unity Bi ...